Formation of DNA adducts in wild-type and transgenic mice expressing human sulfotransferases 1A1 and 1A2 after oral exposure to furfuryl alcohol

被引:9
|
作者
Hoie, Anja Hortemo [1 ]
Monien, Bernhard Hans [2 ]
Sakhi, Amrit Kaur [3 ]
Glatt, Hansruedi [4 ]
Hjertholm, Hege
Husoy, Trine [1 ]
机构
[1] Norwegian Inst Publ Hlth, Div Environm Med, Dept Food Water & Cosmet, N-0456 Oslo, Norway
[2] German Inst Human Nutr DIfE Potsdam Rehrbrucke, Res Grp Genotox Food Contaminants, D-14558 Nuthetal, Germany
[3] Norwegian Inst Publ Hlth, Div Environm Med, Dept Exposure & Risk Assessment, N-0456 Oslo, Norway
[4] German Inst Human Nutr DIfE Potsdam Rehbrbucke, Dept Nutr Toxicol, Nuthetal, Germany
基金
芬兰科学院;
关键词
VOLATILE FLAVOR COMPONENTS; SISTER-CHROMATID EXCHANGES; TISSUE DISTRIBUTION; HUMAN-LYMPHOCYTES; AROMA COMPOUNDS; PRODUCTS; MUTAGENICITY; INDUCTION; INVITRO; SYSTEMS;
D O I
10.1093/mutage/gev023
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Furfuryl alcohol (FFA) is present in many heat-treated foods as a result of its formation via dehydration of pentoses. It is also used legally as a flavouring agent. In an inhalation study conducted in the National Toxicology Program, FFA showed some evidence of carcinogenic activity in rats and mice. FFA was generally negative in conventional genotoxicity assays, which suggests that it may be a non-genotoxic carcinogen. However, it was recently found that FFA is mutagenic in Salmonella strains expressing appropriate sulfotransferases (SULTs), such as human or mouse SULT1A1. The same DNA adducts that were formed by FFA in these strains, mainly N-2-((furan-2-yl)methyl)-2'-deoxyguanosine (N-2-MF-dG), were also detected in tissues of FFA-exposed mice and even in human lung specimens. In the present study, a single oral dose of FFA (250 mg/kg body weight) or saline was administered to FVB/N mice and transgenic mice expressing human SULT1A1/1A2 on the FVB/N background. The transgenic mice were used, since human and mouse SULT1A1 substantially differ in substrate specificity and tissue distribution. DNA adducts were studied in liver, kidney, proximal and distal small intestine as well as colon, using isotope-dilution ultra performance liquid chromatography (UPLC-MS/MS). Surprisingly, low levels of adducts that may represent N-2-MF-dG were detected even in tissues of untreated mice. FFA exposure enhanced the adduct levels in colon and liver, but not in the remaining investigated tissues of wild-type (wt) mice. The situation was similar in transgenic mice, except that N2-MF-dG levels were also strongly enhanced in the proximal small intestine. These different results between wt and transgenic mice may be attributed to the fact that human SULT1A1, but not the orthologous mouse enzyme, is strongly expressed in the small intestine.
引用
收藏
页码:643 / 649
页数:7
相关论文
共 50 条
  • [21] Models of HIV type 1 proviral gene expression in wild-type HIV and MLV/HIV transgenic mice
    Dickie, P
    Gazzinelli, R
    Chang, LJ
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1996, 12 (12) : 1103 - 1116
  • [22] Induction of Protective Immunity by Vaccination With Wild-Type Apo Superoxide Dismutase 1 in Mutant SOD1 Transgenic Mice
    Takeuchi, Shigeko
    Fujiwara, Noriko
    Ido, Akemi
    Oono, Miki
    Takeuchi, Yuki
    Tateno, Minako
    Suzuki, Keiichiro
    Takahashi, Ryosuke
    Tooyama, Ikuo
    Taniguchi, Naoyuki
    Julien, Jean-Pierre
    Urushitani, Makoto
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2010, 69 (10): : 1044 - 1056
  • [23] Developmental maturation of intestinal and renal thiamin uptake: Studies in wild-type and transgenic mice carrying human THTR-1 and 2 promoters
    Reidling, JC
    Nabokina, SM
    Balamurugan, K
    Said, HM
    JOURNAL OF CELLULAR PHYSIOLOGY, 2006, 206 (02) : 371 - 377
  • [24] In Vivo Absorption and Disposition of Cefadroxil After Escalating Oral Doses in Wild-Type and PepT1 Knockout Mice
    Posada, Maria M.
    Smith, David E.
    PHARMACEUTICAL RESEARCH, 2013, 30 (11) : 2931 - 2939
  • [25] In Vivo Absorption and Disposition of Cefadroxil After Escalating Oral Doses in Wild-Type and PepT1 Knockout Mice
    Maria M. Posada
    David E. Smith
    Pharmaceutical Research, 2013, 30 : 2931 - 2939
  • [26] Morphological Differences Between Wild-Type and Transgenic Superoxide Dismutase 1 Lumbar Motoneurons in Postnatal Mice
    Amendola, Julien
    Durand, Jacques
    JOURNAL OF COMPARATIVE NEUROLOGY, 2008, 511 (03) : 329 - 341
  • [27] Overexpression of Wild-Type Human Alpha-Synuclein Causes Metabolism Abnormalities in Thy1-aSYN Transgenic Mice
    Cuvelier, Elodie
    Mequinion, Mathieu
    Leghay, Coline
    Sibran, William
    Stievenard, Alicia
    Sarchione, Alessia
    Bonte, Marie-Amandine
    Vanbesien-Mailliot, Christel
    Viltart, Odile
    Saitoski, Kevin
    Caron, Emilie
    Labarthe, Alexandra
    Comptdaer, Thomas
    Semaille, Pierre
    Carrie, Helene
    Mutez, Eugenie
    Gressier, Bernard
    Destee, Alain
    Chartier-Harlin, Marie-Christine
    Belarbi, Karim
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2018, 11
  • [28] Impact of Peptide Transporter 1 on the Intestinal Absorption and Pharmacokinetics of Valacyclovir after Oral Dose Escalation in Wild-Type and PepT1 Knockout Mice
    Yang, Bei
    Hu, Yongjun
    Smith, David E.
    DRUG METABOLISM AND DISPOSITION, 2013, 41 (10) : 1867 - 1874
  • [29] Analysis of Differentially Expressed Genes in Gastrocnemius Muscle between DGAT1 Transgenic Mice and Wild-Type Mice
    Ying, Fei
    Gu, Hao
    Xiong, Yuanzhu
    Zuo, Bo
    BIOMED RESEARCH INTERNATIONAL, 2017, 2017
  • [30] High-level neuronal expression of Aβ1-42 in wild-type human amyloid protein precursor transgenic mice:: Synaptotoxicity without plaque formation
    Mucke, L
    Masliah, E
    Yu, GQ
    Mallory, M
    Rockenstein, EM
    Tatsuno, G
    Hu, K
    Kholodenko, D
    Johnson-Wood, K
    McConlogue, L
    JOURNAL OF NEUROSCIENCE, 2000, 20 (11): : 4050 - 4058